310 results on '"Kerwin, R. W."'
Search Results
2. RNA editing of the 5-HT2C receptor is reduced in schizophrenia
3. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study
4. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine
5. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole – a 123I IBZM single photon emission tomography (SPET) study
6. Long-term estrogen therapy and 5-HT2A receptor binding in postmenopausal women; a single photon emission tomography (SPET) study
7. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia
8. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study
9. Partial agonism and schizophrenia
10. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression
11. IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up
12. Striatal and extra-striatal D2/D3 dopamine receptor occupancy by quetiapine in vivo: [123I]-epidepride single photon emission tomography (SPET) study
13. Difficulties in replication of results
14. Pharmacogenetic prediction of clozapine response
15. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand123 I-5-I-R-91150
16. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy
17. Cost-effectiveness of clozapine
18. Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99m TcHMPAO single photon emission tomography (SPET)
19. Serotonin: 5-HT sub 2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole
20. Regional cerebral blood flow in obsessive-compulsive disorder measured by 99Tcm-HMPAO uptake and SPET: Differential correlates with obsessive-compulsive and anxious-avoidant features
21. GABAA receptor density and clinical dimensions of schizophrenia: A 123I-Iomazenil SPET investigation
22. 104. D2 dopamine receptor blockade with the atypical antipsychotics remoxipride and risperidone: a 123I-IBZM SPET study
23. 47. D2 dopamine receptor abnormalities in schizoprhenia: a 123I-IBZM SPET study
24. 46. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99Tcm-HMPAO split-dose single photon emission tomographic study
25. 45. D2 dopamine receptor blockade and response to anti-psychotic treatment: a 123I-IBZM SPET study
26. The serotonin transporter and clozapine response
27. Erratum: Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression
28. 123I-IBZM SPECT brain imaging in schizophrenia
29. Serotonin:5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole
30. Pharmacogenomics--can genetics help in the care of psychiatric patients?
31. Heat Stroke in Schizophrenia During Clozapine Treatment: Rapid Recognition and Management
32. The role of atypical antipsychotic drugs in schizophrenia
33. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).
34. Levels of gamma-Aminobutyric Acid-Benzodiazepine Receptors in Abstinent, Alcohol-Dependent Women: Preliminary Findings From an 123I-Iomazenil Single Photon Emission Tomography Study
35. Levels of ??-Aminobutyric Acid-Benzodiazepine Receptors in Abstinent, Alcohol-Dependent Women: Preliminary Findings From an 123I-Iomazenil Single Photon Emission Tomography Study
36. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [ 123 I]epidepride single photon emission tomography (SPET) study
37. The new atypical antipsychotics: a lack of extrapyramidal side-effects and new routes in schizophrenia research / R.W. Kerwin.
38. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response
39. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole
40. 66. The effect of clozapine on extra-striatal dopamine D2 receptor binding in vivo
41. 67. Initial findings in medicated schizophrenic patients using the novel 5-HT2A ligand 123I-5-I-R91150
42. 65. Reduced levels of the GABA benzodiazepine receptor in alcohol dependency
43. In vivo effects on striatal dopamine D 2 receptor binding by the novel atypical antipsychotic drug sertindole - a 123 I IBZM single photon emission tomography (SPET) study
44. Psychiatric Neuroscience Old: Wine in New Bottles - Seminars in Basic Neurosciences is published by Gaskell, London (1994, 328 pp., £15.00) and edited by Gethin Morgan and Stuart Butler. Gethin Morgan is Professor of Mental Health at the University of Bristol. Stuart Butler is Scientific Director at the Burden Neurological Institute, Bristol BS16 1QT. - The Molecular Foundations of Psychiatry is published by American Psychiatric Press, Washington, DC (1994, 239 pp.). The authors are Steven E. Hyman and Eric J. Nestler. Steven Hyman is Director, Division on Addictions at Harvard Medical School; and Assistant Professor of Psychiatry and Neuroscience, Massachusetts General Hospital and Harvard Medical School, Boston, MA. Eric Nestler is Director, Division of Molecular Psychiatry, Elizabeth Mears and House Jameson Associate Professor of Psychiatry and Pharmacology, Connecticut Mental Health Center and Yale University School of Medicine, New Haven, Connecticut. - Molecular and Cell Biology of Neuropsychiatric Diseases is published by Chapman & Hall, London (1994, 201 pp., £45.00 (hb)). The editors are Frank Owen and Ruth Itzhaki. Frank Owen is Professor of Neuroscience at the University of Manchester, UK. Ruth Itzhaki is Reader in the Department of Optometry and Vision Science, Molecular Neurobiology Laboratory, at the Manchester Institute of Science and Technology (UMIST), UK.
45. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia
46. The New Atypical Antipsychotics
47. D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients
48. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone
49. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study
50. 13. Regional cerebral blood flow during verbal memory challenge ??? a split-dose single photon emission tomography (SPET) study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.